Xiao, Y.; Chen, K.; Hu, T.; Wang, Y.; Wang, J.; Lv, C.; Xu, J.; Zhang, X.; Li, A.; Chen, B.;
et al. A Bionic “Trojan Horse”-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy. Pharmaceutics 2025, 17, 507.
https://doi.org/10.3390/pharmaceutics17040507
AMA Style
Xiao Y, Chen K, Hu T, Wang Y, Wang J, Lv C, Xu J, Zhang X, Li A, Chen B,
et al. A Bionic “Trojan Horse”-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy. Pharmaceutics. 2025; 17(4):507.
https://doi.org/10.3390/pharmaceutics17040507
Chicago/Turabian Style
Xiao, Yuai, Kexin Chen, Tianchi Hu, Yuchong Wang, Jing Wang, Chuan Lv, Jianguo Xu, Xinyi Zhang, Ang Li, Bingdi Chen,
and et al. 2025. "A Bionic “Trojan Horse”-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy" Pharmaceutics 17, no. 4: 507.
https://doi.org/10.3390/pharmaceutics17040507
APA Style
Xiao, Y., Chen, K., Hu, T., Wang, Y., Wang, J., Lv, C., Xu, J., Zhang, X., Li, A., Chen, B., Zhu, J., Wu, M., & Xue, C.
(2025). A Bionic “Trojan Horse”-like Nanovesicle Delivery System Hybridized with BCG Cytoplasmic Membrane and Melanoma Cell Membrane for Cancer Immunotherapy. Pharmaceutics, 17(4), 507.
https://doi.org/10.3390/pharmaceutics17040507